Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

2

Revenue 2017

Revlimid

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Revlimid was produced by Celgene.

Sanofi's Darzalex rival scores in myeloma trial

Sanofi's Darzalex rival scores in myeloma trial Celgene’s Revlimid (lenalidomide) and dexamethasone.

BMS isn’t phased by Opdivo’s slowing growth – for now

BMS isn’t phased by Opdivo’s slowing growth – for now over Celgene’s top-seller Revlimid (lenalidomide), which accounts for almost two-thirds of its sales but is facing the threat of generic competition in the coming years.

BMS and Celgene deal sparks debate on pharma profit motive, more M&A

BMS and Celgene deal sparks debate on pharma profit motive, more M&A However there were also those pointing to what many see as Celgene’s abuse of patents and US regulations to protect Revlimid, its top-selling myeloma treatment, which earned over $8bn ... These rows have generated uncertainty about when Revlimid will

BMS and Celgene announce $74bn merger

BMS and Celgene announce $74bn merger setbacks in 2018 as it sought to grow beyond its myeloma blockbuster Revlimid.

Dragonfly signs Celgene as partner for NK cell platform

Dragonfly signs Celgene as partner for NK cell platform Celgene has been signing a string of research partnerships and licensing deals in the last couple of years to diversify its portfolio and reduce its reliance on Revlimid (lenalidomide), a drug

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
An agency called Owen

We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....

Latest intelligence

Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...
Generation Z
The roaring ‘20s and Generation Z
How a new generation will shape pharma comms this decade...

Infographics